Toyama Chemical Company, Ltd.
2-5, Nishishinjuku 3-chome
Shinjuku-ku
Tokyo
160-0023
Tel: 81-3-5381-3889
Fax: 81-3-3348-6460
Website: http://www.toyama-chemical.co.jp/
15 articles about Toyama Chemical Company, Ltd.
-
Eisai And Toyama Chemical Clear All-Case Surveillance Condition For Approval Of Antirheumatic Agent Iguratimod
12/1/2015
-
Ebola Clinical Trials: Big Name Players In The Ebola Race
10/28/2014
-
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus
10/6/2014
-
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus
9/26/2014
-
Cempra Pharmaceuticals, Inc. Gets $10 Million Milestone Payment From Toyama Chemical Company
9/9/2014
-
Toyama Chemical NDA Approval Of “AVIGAN Tablet 200mg” In Japan For The Anti-influenza Virus Drug
3/24/2014
-
Cempra Pharmaceuticals, Inc., Toyama Chemical Company Ink Up to $70 Million Pact to Produce Anti-Pneumonia Drug
5/14/2013
-
Eisai Company, Ltd. and Toyama Chemical Company Receive Approval to Market Anti-rheumatic Agent Iguratimod in Japan
6/29/2012
-
FUJIFILM Holdings Corporation Launches $1.45B bid for Toyama Chemical Company
2/13/2008
-
Toyama Chemical Company Chemical Submits IND For Its Anti-Influenza Compound 'T-705'
1/25/2007
-
Toyama Chemical Company Says Schering-Plough Corporation Pulls US Antibiotic Filing
8/21/2006
-
Toyama Chemical Company Launches Phase I Clinical Trials Of Anti-rheumatic Agent T-5224
6/23/2006
-
Toyama Chemical Company Files New Drug Application For New-type Quinolone Antibiotic
6/5/2006
-
Schering-Plough Corporation Reports Garenoxacin NDA Accepted For FDA Review
2/13/2006
-
Astellas Pharma Inc. And Toyama Chemical Company Agree On Joint Development Of Quinolone Antibiotic T-3811 In Japan
1/30/2006